Font Size: a A A
Keyword [Major histocompatibility]
Result: 81 - 99 | Page: 5 of 5
81. Molecular insights into major histocompatibility complex class I folding and assembly
82. Defining the mechanism of MHC class II peptide editing by HLA-DM: I. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. II. Mapping the interaction surface of DR1 with DM by superantigen blocking. III. Determinat
83. Studies of the immunobiology of the human major histocompatibility complex class Ib molecule, HLA-E
84. Structural and functional studies of major histocompatibility complex class II
85. Development, validation, and application of a method to characterize major histocompatibility complex associated peptides from equivalent to 1x10(8) cells
86. Major histocompatibility complex (MHC) class II tumor vaccines present endogenous antigens through a novel pathway
87. Major histocompatibility complex class II-transfected tumor cells present peptides from endogenously encoded antigen in vitro and in vivo
88. The binding and presentation of peptide antigens by class I major histocompatibility molecules
89. Generation of soluble class II major histocompatibility complex molecules and analysis of histidine participation in enhanced peptide binding at low pH
90. Characterization of major histocompatibility complex haplotypes in a turkey line at the Ohio Agriculture Research and Development Center
91. CELLULAR AND BIOCHEMICAL STUDIES OF CLASS II MOLECULES ENCODED BY THE HLA-D REGION OF THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX
92. Investigating and Manipulating Major Histocompatibility Complex (MHC) Class I-Restricted Peptide Epitopes and Cognate T-cell Responses
93. Expression Of MHC-I Of Lymphocytes In Breast Cancer Patients And Influence On CTL's Cytotoxicity
94. Tumor Immunometabolism Characterization In Ovarian Cancer With Prognostic And Therapeutic Implications
95. Preliminary Study On The Feasibility Of Tumor Specific Presented Antigens As Targets For Antibody Drugs
96. Establishing Of STR Analysis Model For Risk Assessment Of Polygenic Genetic Diseases And Its Experimental Basis
97. Relevant Mechanism Of Endoplasmic Reticulum Aminopeptidase 1 Activating Antiviral Response By Editing HBcAg Immunopeptides
98. Functional Analyisis Of Major Histocompatibility Complex H2-DM? On The Growth And Metastasis Of Melanoma
99. Fine-mapping Of The Major Histocompatibility Complex Region Linked To Leprosy In Northern China
  <<First  <Prev  Next>  Last>>  Jump to